1
|
Gros C, Fleury L, Nahoum V, Faux C, Valente S, Labella D, Cantagrel F, Rilova E, Bouhlel MA, David-Cordonnier MH, Dufau I, Ausseil F, Mai A, Mourey L, Lacroix L, Arimondo PB. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors. J Biol Chem 2014; 290:6293-302. [PMID: 25525263 PMCID: PMC4358266 DOI: 10.1074/jbc.m114.594671] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Among the epigenetic marks, DNA methylation is one of the most studied. It is highly deregulated in numerous diseases, including cancer. Indeed, it has been shown that hypermethylation of tumor suppressor genes promoters is a common feature of cancer cells. Because DNA methylation is reversible, the DNA methyltransferases (DNMTs), responsible for this epigenetic mark, are considered promising therapeutic targets. Several molecules have been identified as DNMT inhibitors and, among the non-nucleoside inhibitors, 4-aminoquinoline-based inhibitors, such as SGI-1027 and its analogs, showed potent inhibitory activity. Here we characterized the in vitro mechanism of action of SGI-1027 and two analogs. Enzymatic competition studies with the DNA substrate and the methyl donor cofactor, S-adenosyl-l-methionine (AdoMet), displayed AdoMet non-competitive and DNA competitive behavior. In addition, deviations from the Michaelis-Menten model in DNA competition experiments suggested an interaction with DNA. Thus their ability to interact with DNA was established; although SGI-1027 was a weak DNA ligand, analog 5, the most potent inhibitor, strongly interacted with DNA. Finally, as 5 interacted with DNMT only when the DNA duplex was present, we hypothesize that this class of chemical compounds inhibit DNMTs by interacting with the DNA substrate.
Collapse
Affiliation(s)
- Christina Gros
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Laurence Fleury
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Virginie Nahoum
- Institut de Pharmacologie et de Biologie Structurale (IPBS) CNRS, Toulouse, 31077, France, Université de Toulouse, UPS, IPBS, Toulouse, 31077, France
| | - Céline Faux
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Sergio Valente
- Sapienza University of Rome, Department of Chemistry and Technology of Drug, Sapienza University of Rome, I-00185 Roma, Italy
| | - Donatella Labella
- Sapienza University of Rome, Department of Chemistry and Technology of Drug, Sapienza University of Rome, I-00185 Roma, Italy
| | - Frédéric Cantagrel
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Elodie Rilova
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Mohamed Amine Bouhlel
- INSERM UMR837-JPARC (Jean-Pierre Aubert Research Center), Team 4, IRCL, 59045 Lille, France
| | | | - Isabelle Dufau
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Frédéric Ausseil
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France
| | - Antonello Mai
- Sapienza University of Rome, Department of Chemistry and Technology of Drug, Sapienza University of Rome, I-00185 Roma, Italy, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, I-00185 Roma, Italy, and
| | - Lionel Mourey
- Institut de Pharmacologie et de Biologie Structurale (IPBS) CNRS, Toulouse, 31077, France, Université de Toulouse, UPS, IPBS, Toulouse, 31077, France
| | | | - Paola B Arimondo
- From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France,
| |
Collapse
|
3
|
Moyer R, Briley D, Johnsen A, Stewart U, Shaw BR. Echinomycin, a bis-intercalating agent, induces C-->T mutations via cytosine deamination. Mutat Res 1993; 288:291-300. [PMID: 7688090 DOI: 10.1016/0027-5107(93)90097-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Echinomycin, a bis-intercalating, antitumor drug, has been studied for its ability to induce the deamination of cytosine to uracil (C-->U) in double-stranded DNA. We have employed a sensitive lacZ alpha-complementation reversion assay to detect G.C-->A.T mutations at a number of sites in M13mp2 DNA to determine the extent to which distortions of DNA structure induced by echinomycin may affect C-->U rates. When double-stranded M13mp2 DNA with a 12-base target containing a CpG site was incubated at 37 degrees C, the reversion frequency of the echinomycin-treated DNA increased linearly over time, with a rate constant 3-fold greater than DNA incubated without echinomycin. Of the 11 ways that blue pseudo-revertants can occur in the target, 96% of the observed revertants arose from C-->T and tandem CC-->TT transitions, with 78% attributable to single-base C-->T changes at three sites. Transfection into ung+ cells decreased the reversion frequencies by 85% to near background levels, indicating that the increase in C-->T mutations was due to deamination of C to U. The cytosine deamination rate constants for the entire target at pH 6.0 and 37 degrees C were 1.2 x 10(-11) sec-1 for untreated DNA and 3.5 x 10(-11) sec-1 for echinomycin-treated DNA. The increase in C-->T mutation rates occurred at cytosines both proximal and distal to a CpG echinomycin-binding site. We hypothesize that this increase in deamination rate is due to a more open or single-stranded DNA structure caused by the echinomycin: DNA interaction.
Collapse
Affiliation(s)
- R Moyer
- Department of Chemistry, Duke University, Durham, NC 27708-0346
| | | | | | | | | |
Collapse
|
4
|
Lavesa M, Olsen RK, Fox KR. Sequence-specific binding of [N-MeCys3,N-MeCys7]TANDEM to TpA. Biochem J 1993; 289 ( Pt 2):605-7. [PMID: 8424802 PMCID: PMC1132212 DOI: 10.1042/bj2890605] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The sequence selective binding of [N-MeCys3,N-MeCys7]TANDEM to DNA has been studied by footprinting experiments on DNA fragments containing the self-complementary sequences CGCGATATCGCG, CGCGTATACGCG, CGCGTTAACGCG and CGCGAATTCGCG. DNAase I and micrococcal nuclease reveal drug-induced footprints with the central sequences ATAT, TATA and TTAA, but not AATT, suggesting that the ligand binds to the dinucleotide TpA. The ligand renders certain adenines hyper-reactive to diethyl pyrocarbonate. These are observed with ATAT, TATA and TTAA, but not AATT, and are located both within, and distal to, the TpA-binding sites.
Collapse
Affiliation(s)
- M Lavesa
- Department of Physiology and Pharmacology, University of Southampton, U.K
| | | | | |
Collapse
|
5
|
Abstract
The interaction of bleomycin with a kinetoplast DNA fragment has been examined using various footprinting techniques. This DNA adopts a bent structure and displays an unusually low gel mobility on account of its phased runs of adenines. The bleomycin-cobalt complex increases the mobility of this DNA fragment, in contrast with other DNAs which show a decreased rate of gel migration, suggesting that the antibiotic removes DNA bending, possibly via an unwinding mechanism. Removal of the bending is confirmed by hydroxy-radical footprinting which produces a more even ladder of bands in the presence of the ligand. Cleavage by bleomycin is at the sequence G-pyrimidine, though not all such sites are affected to the same extent and some cutting is found at GA and GG. DNase I footprinting confirms the antibiotic-binding sites but reveals that some strong cleavage sites do not yield footprints. Bleomycin renders adenines on the 3' side of its cleavage sites (GT, GC and GA) hyper-reactive to diethyl pyrocarbonate.
Collapse
Affiliation(s)
- K P Nightingale
- Department of Physiology and Pharmacology, University of Southampton, U.K
| | | |
Collapse
|
6
|
Waterloh K, Fox KR. Interaction of echinomycin with An.Tn. and (AT)n regions flanking its CG binding site. Nucleic Acids Res 1991; 19:6719-24. [PMID: 1762902 PMCID: PMC329300 DOI: 10.1093/nar/19.24.6719] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
We have prepared DNA fragments containing the sequences A15CGT15, T15CGA15 and T(AT)8CG(AT)15 cloned within the SmaI site of the pUC19 polylinker. These have been used as substrates in footprinting experiments with DNase I and diethylpyrocarbonate probing the effects of echinomycin, binding to the central CG, on the structure of the surrounding sequences. No clear DNase I footprints are seen with T15CGA15 though alterations in the nuclease susceptibility of surrounding regions suggest that the ligand is binding, albeit weakly at this site. All the other fragments show the expected footprints around the CG site. Regions of An and Tn are rendered much more reactive to DNase I and adenines on the 3'-side of the CG become hyperreactive to diethylpyrocarbonate. Regions of alternating AT show unusual changes in the presence of the ligand. At low concentrations (5 microM) cleavage of TpA is enhanced, whereas at higher concentrations a cleavage pattern with a four base pair repeat is evident. A similar pattern is seen with micrococcal nuclease. Modification by diethylpyrocarbonate is strongest at alternate adenines which are staggered in the 5'-direction across the two strands. We interpret these changes by suggesting secondary drug binding within regions of alternating AT, possibly to the dinucleotide ApT. DNase I footprinting experiments performed at 4 degrees C revealed neither enhancements nor footprints for flanking regions of homopolymeric A and T suggesting that the conformational changes are necessary consequence of drug binding.
Collapse
Affiliation(s)
- K Waterloh
- Department of Physiology & Pharmacology, University of Southampton, UK
| | | |
Collapse
|
7
|
Abstract
We have studied the binding of echinomycin to DNA fragments containing GC-rich regions flanked by blocks of alternating AT by DNase I footprinting and diethylpyrocarbonate modification. Regions of alternating AT flanking the sequences CCCG, CCGC, CGGC and GG show a four base pair DNase I cleavage pattern and reaction of alternate adenines with diethylpyrocarbonate. This pattern is strongest when the AT-block is immediately adjacent to the CpG ligand binding site. We explain these phenomena by suggesting that echinomycin binds to the dinucleotide step ApT in a cooperative fashion. The cooperative effects can be transmitted through the dinucleotide step GC but not CC or AA. No such repetitive patterns are seen with surrounding regions of (ATT).(AAT). Evidence is presented for secondary drug binding sites at CpC and TpG with weaker interaction at the CpG site within the hexanucleotide TTCGAA.
Collapse
Affiliation(s)
- K R Fox
- Department of Physiology & Pharmacology, University of Southampton, UK
| | | | | |
Collapse
|
8
|
Cons BM, Fox KR. Effects of sequence selective drugs on the gel mobility of a bent DNA fragment. Biochem Biophys Res Commun 1990; 171:1064-70. [PMID: 1699520 DOI: 10.1016/0006-291x(90)90792-l] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The effects of various drugs on the structure of a bent DNA fragment have been investigated by studying DNA mobility in polyacrylamide gels. This DNA fragment has an anomalously slow rate of migration on account of its phased runs of adenines. Nogalamycin and echinomycin increase the gel mobility of kinetoplast DNA suggesting that the bending has been removed. Mithramycin, actinomycin, distamycin and ethidium have either no effect or cause a further reduction in mobility. These results are compared with other, non-bent DNA species which always show a decrease in gel mobility in the presence of DNA binding drugs.
Collapse
Affiliation(s)
- B M Cons
- Dept. of Physiology & Pharmacology, University of Southampton, U.K
| | | |
Collapse
|